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Background: Chemokines contribute to inflammatory responses by inducing leukocyte 
  migration and extravasation. In addition, chemoattractants other than classical chemokines can 
also be present. Many chemokines have been demonstrated to cooperate, leading to an aug-
mentation in leukocyte recruitment and providing a potential role for the presence of multiple 
chemoattractants. Extracellular cyclophilins are a group of alternative chemotactic factors, 
which can be highly elevated during various inflammatory responses and, as we have previously 
shown, can contribute significantly to neutrophil recruitment in an animal model of acute lung 
inflammation. In the current studies we investigated whether the most abundant extracellular 
cyclophilin, CypA, has the capacity to function in partnership with 2 classical chemokines 
known to be secreted in the same model, macrophage inflammatory protein (MIP)-2/CXCL2 
and keratinocyte chemoattractant (KC)/CXCL1.
Methods: Neutrophil migration in response to combinations of CypA and MIP-2 or CypA 
and KC was measured by in vitro chemotaxis assays. Biochemical responses of neutrophils 
incubated with the combinations of chemoattractants were determined by changes in chemokine 
receptor internalization and actin polymerization measured by flow cytometry, and changes in 
intracellular calcium mobilization measured with a calcium sensitive fluorochrome.
Results: A combination of CypA and MIP-2, but not KC, augmented neutrophil migration. 
Based on the level of augmentation, the cooperation between CypA and MIP-2 appeared to be 
synergistic. Evidence that CypA and MIP-2 cooperate at the biochemical level was demonstrated 
by increases in receptor internalization, calcium mobilization, and actin polymerization.
Conclusion: These findings provide evidence for the capacity of extracellular cyclophi-
lins to interact with classical chemokines, resulting in greater and more efficient leukocyte 
recruitment.
Keywords: chemokine, chemotaxis, inflammation
Introduction
Neutrophils are integral leukocytes in the monitoring of the immune system and the host 
response to inflammation. The main regulators of leukocyte trafficking are chemokines, 
a family of chemoattracting cytokines. Chemokines induce cell migration by binding 
to and signaling through G-protein-coupled receptors (GPCRs) on their target cells. 
While GPCRs for chemokines are restricted to interaction with specific families of 
this class of chemoattractants, notably CC versus CXC, many can act as receptors for 
several different members within a family. The fact that inflammatory processes are 
usually associated with the production of many different chemokines, some of which 
target the same leukocyte subset or even the same specific receptors on target cells, 
suggests a significant overlap and/or redundancy in function by chemokines.Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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To add to the already complex mix of multiple   chemokines 
is the finding that additional factors with chemoattracting 
properties can also be present during inflammatory responses, 
for example, cyclophilins, a family of intracellular proteins 
that are ubiquitously expressed in all organisms and in all 
human tissues. Cyclophilins can be secreted by different cell 
types in response to inflammatory stimuli such as LPS1,2 or 
reactive oxygen radicals,3 thereby generating extracellular 
pools of these proteins. Indeed, high levels of extracellular 
cyclophilins have been reported in several inflammatory 
diseases, both in humans 2,4,5 and mice.6–8 We have previously 
proposed that extracellular cyclophilins might play a role in 
inflammatory processes by contributing to the recruitment 
of leukocytes to sites of ongoing inflammation.9 Indeed, 
using 3 different animal models of inflammatory disease, 
our laboratory demonstrated that inhibiting the chemotactic 
function of cyclophilins using either a nonimmunosuppres-
sive analog of CsA6 or an antibody to the principal signaling 
receptor for extracellular cyclophilins A and B, CD147,6–8 can 
significantly reduce leukocyte recruitment in vivo.
Studies in which classical chemokines are inhibited also 
demonstrate significant reductions in leukocyte recruitment. 
In the case of neutrophils, for example, mice given anti-
MIP-2 antibody showed a significantly reduced neutrophil 
influx into lungs challenged with bacteria10 and also into 
LPS-treated air pouches.11 Treatment with a blocking anti-
body against the CXC chemokine, LIX (CXCL5), signifi-
cantly decreased neutrophil migration to airways and lungs 
of mice in an LPS model of acute lung injury.12 Inhibiting 
the signaling function of another chemokine, CCL2, using 
mice lacking CCR2 receptors, resulted in a greater than 
90% decrease in alveolar neutrophil influx.13 Given that 
the total contribution of all reported chemokines, as well as 
non-classical chemokines, produced during an inflammatory 
response cannot be greater than 100%, the possibility that 
some of these chemoattracting factors might cooperate has 
been explored from different mechanistic perspectives.
One such mechanism is chemokine synergy in which 
the total chemotactic function that is mediated by combin-
ing 2 chemokines is greater than their additive individual 
functions. Therefore, when one chemokine in a coopera-
tive partnership is inhibited, the function of the second 
chemokine is indirectly impacted, resulting in a greater total 
reduction in cell recruitment and a potential explanation for 
the   apparent .100% inhibition in leukocyte recruitment 
when individual effects are added together. Many different 
chemokines have been shown to work in partnership both in 
vitro and in vivo, with the potential to amplify inflammatory 
responses (reviewed in14). Following from our long-standing 
interest in the contribution of extracellular cyclophilins as 
chemoattractants during inflammatory responses, we inves-
tigated in the current studies whether cyclophilin A (CypA), 
the most abundant member of the cyclophilin family,15 
might have a similar capacity to cooperate with classical 
chemokines to mediate augmented leukocyte migration. In 
previous studies we showed that CypA is a potent inducer 
of neutrophil migration in vitro and that high levels of CypA 
are present in the airways of mice with ongoing pulmonary 
neutrophilia induced by intranasal administration of LPS.6 
We therefore examined whether combining CypA with 
other known neutrophil-attracting chemokines would lead 
to an increase in neutrophil recruitment, and the impact of 
these combinations on biochemical events associated with 
cell migration.
In this report we show that CypA is able to cooperate with 
MIP-2, but not KC, to induce a synergistic augmentation in 
neutrophil migration in vitro. Analysis of various parameters 
associated with cell migration demonstrated that neutrophils 
stimulated with a combination of CypA and MIP-2 showed 
greater increases in GPCR (CXCR2) internalization, intracel-
lular calcium mobilization, and actin polymerization, relative 
to cells stimulated with the individual chemoattractants. 
These additional increases were not observed in neutrophils 
stimulated with combinations of CypA and KC. Taken 
together, these findings provide evidence that CypA has the 
capacity to interact with selective classical chemokines to 
mediate an augmented neutrophil migration that is associated 
with enhanced biochemical events.
Material and methods
Animals
Female C57BL/6 mice, at least 6 weeks of age, were used for 
these studies and were purchased from the National Cancer 
Institute (Bethesda, MD). Blood, or bone marrow, was pooled 
from 2 to 5 age-matched animals for each experiment. All 
studies were reviewed and approved by the Institutional 
Animal Care and Use committee at The George Washington 
University.
Reagents
PE-conjugated anti-mouse Gr-1 was purchased from BD 
Biosciences (San Jose, CA) and APC-conjugated anti-mouse 
Gr-1 was purchased from eBioscience (San Diego, CA). PE-
conjugated anti-mouse CXCR2 and rat IgG2A isotype were 
purchased from R&D Systems (Minneapolis, MN). FITC-
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IgG1 isotype control were purchased from Abcam (Cambridge, 
MA). FITC-labeled phalloidin for actin polymerization stud-
ies was purchased from Sigma-Aldrich (St. Louis, MO). 
Anti-human cyclophilin A mAb (cross-reacts with mouse 
cyclophilin A) was obtained from US Biological (Swampscott, 
MA), and HRP-conjugated donkey anti-rabbit secondary Ab 
was purchased from Amersham Biosciences (Piscataway, 
NJ). fMLP, and BSA Fraction V were obtained from Sigma-
Aldrich. Human recombinant CypA, which differs from mouse 
CypA by only one amino acid residue, was purchased from 
  Calbiochem (San Diego, CA). Recombinant mouse MIP-2 
and KC were purchased from PeproTech (Rocky Hill, NJ). 
FLIPR calcium 3 assay kit component A fluorescent dye for 
calcium   measurements was purchased from Molecular Devices 
  (Sunnyvale, CA) and dATP from Invitrogen (Carlsbad, CA).
neutrophil enrichment for in vitro assays
For chemotaxis assays: mouse peripheral blood was col-
lected by cardiac puncture. The collected blood was treated 
with RBC lysis buffer and the neutrophils were then isolated 
using a MACS Gr-1 positive selection kit (Miltenyi Biotech, 
Aurora, CA). For actin polymerization and intracellular cal-
cium experiments: bone marrow-derived neutrophils were 
obtained by flushing tibias and femurs of C57BL/6 mice with 
HBSS. The isolated bone marrow was washed with HBSS, 
centrifuged at 300 g for 12 minutes, and resuspended in 
6 mL HBSS. The cells were layered on top of a Histopaque 
1077/1119 gradient (3 mL Histopaque 1119 overlayed with 
3 mL Histopaque 1077) and centrifuged at room temperature 
for 30 minutes at 700 g. The resulting granulocyte layer 
was removed, washed, and then used for phalloidin stain-
ing or calcium assays. For receptor internalization studies: 
mouse peripheral blood was collected by cardiac puncture. 
The collected blood was treated with RBC lysis buffer 
and the neutrophils were then isolated using an EasySep 
Mouse Neutrophil Enrichment Kit (Stem Cell Technologies 
Vancouver, BC, Cananda). Purity for all enriched populations 
was established to be 80 to 90% by FACS analysis.
chemotaxis assays
Chemotaxis assays were set up using 48-well modified 
Boyden chambers (Neuro Probe Inc., Gaithersburg, MD) 
with the 2 compartments separated by a 5-µm   polycarbonate 
membrane (Neuro Probe). Neutrophils (104 cells/well) in 
RPMI 1640 culture medium supplemented with 1% BSA 
were added to the upper chamber wells, while media con-
taining different doses and combinations of chemoattractants 
(shown in Figures) were added to the lower compartments. 
In some studies purified mouse neutrophils were   preincubated 
in medium alone (RPMI 1640 + 1% BSA fraction V), or 
medium containing doses of recombinant CypA or MIP-2 
(as indicated in figure legends) for 30 minutes before being 
washed in PBS, resuspended in fresh medium, and applied to 
the upper wells of the chamber. A dose of 10-7 M fMLP was 
used as a positive control for neutrophil migration. The cham-
bers were incubated at 37°C in 5% CO2 for 50 minutes, after 
which the chamber membrane was removed, non-migrating 
cells scraped off, and the membrane stained with Wright-
Giemsa (Camco, Fort Lauderdale, FL). A chemotactic 
index was generated for each well by dividing the number 
of cells counted for that well by the number of cells counted 
in media wells.
Receptor expression studies
Purified mouse neutrophils were serum starved in RPMI 1640 
without BSA for 30 minutes at room temperature. This short 
starvation step was included to reduce background staining 
while maintaining maximal cell viability. The cells were 
then supplemented with an equivalent volume of RMPI 1640 
containing 2% BSA fraction V in preparation for stimulation. 
1 × 106 neutrophils in 200 µL volume medium (RMPI + 1% 
BSA fraction V) were set up in a 96-well tissue culture plate. 
Cells were incubated in medium alone, or with recombinant 
CypA, MIP-2, or KC, as well as combinations of the various 
chemoattractants (as indicated in figure legends) for 5 min-
utes at 37°C in 5% CO2. (Five minutes was chosen based on 
initial kinetics studies showing optimal changes at this time 
point). The cells were then removed from wells, washed with 
PBS, and stained with APC-Gr-1 for gating on neutrophils. 
The cells were also stained with either FITC anti-CD147, 
FITC IgG1 isotype control, PE-CXCR2, or PE IgG2A control, 
and expression of CD147 and CXCR2 receptors on Gr-1 
positive cells was determined by flow cytometry.
Intracellular calcium measurements
Intracellular calcium measurements were conducted with 
bone marrow neutrophils using a Benchtop Scanning 
Fluorometer and Integrated Fluid Transfer Workstation 
(FlexStation; Molecular Devices, Sunnyvale, CA). A total of 
1 × 106 cells in 100 µL HBSS + 20 mM HEPES buffer was 
loaded into a 96-well plate together with 100 µL of FLIPR 
calcium 3 assay kit component A fluorescent dye (Molecular 
Devices), and then incubated for 30 min at 37°C. A separate 
plate containing various doses of chemoattractants (shown in 
figure legends) was set up. Both plates were then loaded into 
the FlexStation for automated addition of chemoattractants Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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to the fluorescently labeled cells. Baseline fluorescence was 
established before the chemoattractants were added to cells 
at 20 seconds. Changes in intracellular calcium concentra-
tions in response to added chemoattractants were recorded 
as relative fluorescence units over time. dATP (100 µM) 
was added to all groups of cells at 120 seconds as a positive 
control for equal capacity to flux calcium.
Actin polymerization
Bone marrow neutrophils were serum starved in 500 µL 
RPMI 1640 without BSA for 30 minutes at room temperature 
and then supplemented with 500 µL RMPI 1640 containing 
2% BSA fraction V in preparation for stimulation. 5 × 106 
neutrophils (now in RMPI 1640 with 1% BSA medium) 
were incubated at 37°C in 5% CO2 for 5 minutes in medium 
alone, fMLP as a positive control, CypA, MIP-2, KC alone 
or various combinations, at doses indicated in figure   legends. 
(Five minutes was chosen based on initial kinetics   studies 
  showing optimal changes at this time point). The cells 
were then immediately fixed by adding 3.7% formalin for 
10 minutes at room temperature. Samples were centrifuged 
for 1 minute at 1400 rpm and supernatants discarded. 100 µL 
cold 0.1% Triton X-100 was added to each sample and 
incubated on ice for 30 minutes to permeabilize the cells. 
Samples were washed with FACS buffer and stained with 
6 µg/mL FITC-conjugated phalloidin in FACS buffer at 
room temperature for 40 minutes. Actin polymerization was 
determined by the level of phalloidin expression, as measured 
by flow cytometry.
statistical analysis
Data are summarized as mean ± SE. Statistical analysis of 
the results was performed using an unpaired Student t test, 
with P , 0.05 considered significant.
supplemental material
One supplemental figure is provided. Supplemental 
Figure 1 shows in vitro neutrophil migration in response 
to different doses of CypA, MIP-2, and KC. These titra-
tion curves were used to select suboptimal doses for each 
chemoattractant for the combination studies.
Results
cypa can cooperate with MIP-2,  
but not Kc, in vitro
In previous studies we demonstrated the capacity of CypA 
to induce in vitro migration of human16 and mouse6 neutro-
phils. In the current studies we investigated whether CypA 
might have the capacity to interact with classical chemokines 
known to be potent inducers of neutrophil migration, notably 
MIP-2 and KC, to mediate enhanced migration. Based on 
the findings of others that functional interactions are most 
likely to occur when suboptimal doses of chemokines are 
combined,17 we initially established individual dose response 
curves for all 3 chemoattractants (Supplemental Figure 1) 
and then selected doses in the lower range for testing in our 
combination assays. The data in Figure 1 show results from 
experiments in which neutrophils were set up with a fixed 
dose of MIP-2 or KC plus varying doses of CypA. Our find-
ings demonstrate that combining CypA with MIP-2 induces a 
significant augmentation in neutrophil migration (Figure 1A). 
Interestingly, this augmentation was greater than the additive 
migration induced by MIP-2 alone plus CypA alone, sug-
gesting that the 2 chemokines are interacting in a synergistic 
partnership. No such enhancement in neutrophil migration 
was observed using various combinations of KC and CypA 
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Figure 1 cypa and MIP-2 cooperate in vitro. In vitro chemotaxis assays were set up 
using purified mouse neutrophils incubated in the presence of a single dose of fMlP 
(positive control), a single dose of cypa, MIP-2, or Kc, or a fixed dose of MIP-2 
or Kc plus varying doses of cypa. a chemotactic index was calculated for each 
group by dividing the number of migrated cells in test wells by the number of cells 
that migrated to medium alone. A) Mean + se chemotactic index for neutrophils 
incubated with fMlP, cypa alone, MIP-2 alone, or combinations of MIP-2 plus cypa. 
B) Mean + se chemotactic index for neutrophils incubated with fMlP, cypa alone, 
Kc alone, or combinations of Kc plus cypa. 
Notes: statistical significance was determined by student’s t-test, with n = 6 wells per 
group. *P , 0.05 and ***P , 0.001. These data are representative of .3 independent 
experiments.
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(Figure 1B). Taken together, these findings demonstrate that 
the presence of CypA can significantly increase the capacity 
of MIP-2 to induce neutrophil migration and that this effect 
is more than just additive.
cypa and MIP-2 must be present 
concurrently for cooperation to occur
We next examined whether the augmented neutrophil 
migration observed when CypA and MIP-2 are combined 
requires that the 2 chemoattractants be present concurrently, 
or whether the same effect could be mediated by sequential 
exposure. Thus, in vitro chemotaxis assays were conducted 
in which neutrophils were preincubated with different doses 
of one chemoattractant, washed, and then tested for their 
migratory response to the second chemoattractant. As shown 
in Figure 2A, neutrophils preincubated with CypA did not 
respond either additively or synergistically upon subsequent 
stimulation with MIP-2. Likewise, neutrophils preincubated 
with MIP-2 did not migrate with either an additive or syn-
ergistic response to CypA (Figure 2B). Importantly, in both 
experiments the concurrent exposure to MIP-2 and CypA led 
to a greater than additive increase in neutrophil migration, 
demonstrating the reproducibility of the synergistic interac-
tion when the 2 chemoattractants are present together.
addition of cypa to MIP-2 increases 
cXcR2 internalization
Ligand binding to chemokine receptors triggers a cascade 
of signaling events that ultimately result in cell polariza-
tion and chemotaxis, as well as receptor internalization.18 
Increases in receptor internalization are often used as an 
indicator of increased receptor engagement and/or receptor 
signaling. In the current studies we investigated the impact of 
co-incubation with CypA and MIP-2, relative to incubation 
with the individual chemoattractants, on the internalization 
of CD147 (receptor for CypA19) and CXCR2 (receptor for 
MIP-2) on neutrophils. It should be noted that the same 
low doses of CypA and MIP-2, which demonstrated syner-
gistic responses (Figures 1 and 2), were used in the current 
  studies. Combinations of CypA and KC were also included 
as a comparison for effects mediated by noncooperating 
chemoattractants. Figures 3A, 3B, and 3E show that CD147 
expression was not significantly changed (based on MFI units) 
after incubation with CypA, MIP-2, or KC alone, or with any 
of the chemoattractant combinations. In contrast, stimulation 
with a combination of CypA and MIP-2 resulted in a signifi-
cantly greater CXCR2 receptor internalization (average of 
26% reduction in expression compared with medium alone, 
based on MFI units), relative to that induced by MIP-2 alone 
(13% reduction) (Figures 3C and 3F).   Adding CypA to KC 
did not significantly augment the degree of CXCR2 inter-
nalization mediated by KC alone (11% and 16% reductions, 
respectively) (Figures 3D and 3F). Taken together, these data 
demonstrate a selective increase in CXCR2 internalization 
when CypA and MIP-2 are present in combination, suggesting 
enhanced receptor engagement and/or signaling.
cypa and MIP-2 combination increases 
intracellular calcium mobilization
Intracellular calcium release is triggered upon GPCR binding 
and activation, and therefore increases in intracellular cal-
cium levels are often used as a readout of GPCR activation. 
Similarly, intracellular calcium release is triggered by CD147 
engagement by cyclophilins. Cooperating chemokines have 
been shown to induce enhanced calcium flux when added in 
combination.18,20,21 Having demonstrated increased receptor 
internalization in the presence of CypA and MIP-2, we next 
conducted calcium flux assays to provide further support 
for additive signaling between CypA and MIP-2. Calcium 
release in response to the individual chemoattractants, or 
their combination, was measured in neutrophils in real 
time using a Molecular Devices FlexStation. As shown 
in Figure 4, the greatest increase in intracellular calcium 
levels was observed when CypA and MIP-2 were present 
in combination. Moreover, the increase in calcium flux 
mediated by the combination appeared to be more rapid and 
more prolonged, compared with that mediated by MIP-2 and 
CypA alone. These findings provide additional evidence 
for the capacity of a MIP-2/CypA combination to mediate 
augmented signaling.
cypa and MIP-2 combination stimulates 
increased actin polymerization
F-actin polymerization occurs at the leading edge of neutro-
phils in response to chemokine-mediated GPCR   stimulation. 
Cooperating chemokines have been shown to trigger 
increased actin polymerization when present in combination 
compared with individual chemokines,22 providing a potential 
mechanism for enhanced leukocyte migration by synergiz-
ing chemoattractants. In the current studies neutrophils were 
stimulated with CypA, MIP-2, or KC alone, or with combina-
tions of CypA and MIP-2 or CypA and KC, followed by stain-
ing with FITC-conjugated phalloidin to measure the extent of 
actin polymerization. Phalloidin expression was significantly 
increased in neutrophils incubated with a combination of 
CypA and MIP-2 (average of 33% increase compared with Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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medium alone, based on MFI units), compared with those 
incubated with individual chemoattractants (MIP-2 = 5% 
decrease and CypA = 6% increase) (Figures 5A and 5C). No 
such changes in phalloidin expression were mediated when 
CypA and KC were combined (KC alone = 23% increase 
versus KC + CypA = 14% increase) (Figures 5B and 5C).
Discussion
Neutrophil migration toward sites of infection is integral 
in the innate immune response. Chemokines secreted by 
resident cells in response to inflammatory stimuli establish a 
gradient that induces neutrophils to extravasate and migrate to 
infected tissues. Although beneficial for pathogen clearance, 
the neutrophilia that ensues during inflammatory responses 
often results in extensive bystander tissue   damage.   Neutrophil 
accumulation and activation within tissues contributes 
significantly to the pathology of both autoimmune and non-
autoimmune inflammatory conditions (reviewed in23) and can 
also promote the onset of carcinogenic events (reviewed in24). 
Therefore, understanding how neutrophil recruitment is regu-
lated, including the factors that contribute to this regulation, 
has important therapeutic implications for a wide variety of 
diseases associated with tissue injury.
Many chemokines are secreted during inflammation, 
suggesting either a high degree of redundancy or an overlap 
in function. Interestingly, several chemokines have been 
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Figure 2 cypa and MIP-2 must be present concurrently for in vitro cooperation to occur. In vitro chemotaxis assays were set up using purified mouse neutrophils 
preincubated in the presence of chemotaxis medium, medium containing 5 or 50 ng/ml cypa, or medium containing 10 or 100 ng/ml MIP-2, for 30 minutes. The cells 
were then washed and set up in Boyden chambers with medium alone, 5 ng/ml cypa, or 10 ng/ml MIP-2. cells preincubated in medium alone were set up with a single 
dose of MIP-2, cypa, or a combination of both as a positive control for cooperative interaction. a chemotactic index was calculated for each group by dividing the number 
of migrated cells in test wells by the number of cells preincubated in medium that migrated to medium alone. A) Mean + se chemotactic index of migration to indicated 
chemoattractants for neutrophils preincubated with medium alone, 5 or 50 ng/ml of cypa. B) Mean + se chemotactic index of migration to indicated chemoattractants for 
neutrophils preincubated with medium alone, 10 or 100 ng/ml doses of MIP-2. 
Notes: statistical significance was determined by student’s t-test, with n = 6 wells per group. *P , 0.05. These data are representative of .3 independent experiments.
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Figure 3 cXcR2 internalization increases when cypa and MIP-2 are combined. Purified neutrophils were incubated in medium alone or with the indicated combination of 
5 ng/ml cypa, 10 ng/ml MIP-2, or 20 ng/ml Kc, for 5 minutes. cells were then washed in PBs and stained with either FITc-conjugated anti-cD147 or FITc-conjugated 
isotype control ab, or Pe-conjugated anti-cXcR2 or Pe-conjugated isotype control aB. A) cD147 expression on cells incubated with cypa alone, MIP-2 alone, or a 
combination of cypa + MIP-2. B) cD147 expression on neutrophils incubated with cypa alone, Kc alone, or a combination of cypa + Kc. C) cXcR2 expression on 
neutrophils incubated with cypa alone, MIP-2 alone, or a combination of cypa + MIP-2. D) cXcR2 expression on neutrophils incubated with cypa alone, Kc alone, 
or a combination of cypa + Kc. MFI were calculated and are shown for each group in panel legends. Bar graphs showing average decrease in MFI relative to medium for 
E) cD147 expression and F) cXcR2 expression were calculated using 3 independent sets of data.
Abbreviations: see list of abbreviations.
shown to work in partnership with the potential to amplify 
inflammatory responses. For example, studies with the 
CC plasma chemokine, Regakine-1, showed a synergis-
tic enhancement in neutrophil migration when combined 
with IL-8 (CXCL8), GCP-2 (CXCL6), MCP-3 (CCL7),25 
or with NAP-226 in vitro, and when co-administered with 
GCP-2 in vivo.27 Interestingly, Regakine-1 was also shown 
to   synergize with a chemotactic anaphylatoxin, C5a,26 sug-
gesting that these types of interactions are not restricted 
to classical chemokines. Other studies have found that Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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Dovepress
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IL-8 cooperates with GM-CSF in the female reproductive 
tract, resulting in enhanced   neutrophil   chemotaxis.28 This 
enhanced recruitment was inhibited by up to 95% when the 
2   chemokines were neutralized in combination.28 RANTES 
(CCL5) and MCP-1 (CCL2) were shown to work together to 
enhance the migration of PBMCs in vitro18 and the in vivo 
co-injection of RANTES and IP-10 (CXCL10) was reported 
to augment T lymphocyte recruitment.29 IP-10 has also been 
shown to increase the migration of Th1 and Th2 clones when 
combined with MDC (CCL22) in vitro.22 Extracellular cyclo-
philins are another family of proteins with chemoattracting 
properties that are elevated during inflammatory responses. 
Our laboratory has previously demonstrated that extracel-
lular cyclophilins contribute significantly to neutrophil 
recruitment in a mouse model of LPS-induced lung inflam-
mation.6 Inhibiting the function of cyclophilins reduced the 
influx of neutrophils by 40%–50% in this model.6 Given the 
many other neutrophil-recruiting chemokines known to be 
present following LPS challenge,12 we investigated in the 
current studies whether cyclophilins might have the capacity 
to synergize with MIP-2 and/or KC, the major neutrophil-
attracting chemokines in this disease.
In initial in vitro chemotaxis studies we observed a potent 
functional interaction between CypA and MIP-2, but not 
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Figure 4 The combination of cypa and MIP-2 increases neutrophil calcium flux. 
neutrophils  (106)  were  incubated  for  30  minutes  at  37°c  in  fluorescent  dye 
followed by exposure to chemoattractants (5 ng/ml cypa alone, 10 ng/ml MIP-2 
alone, or cypa and MIP-2 combined) at the time indicated by arrows. changes in 
intracellular calcium levels were monitored over time by changes in fluorescence 
intensity using the Flexstation system (Molecular Devices). The % increase in ca2+ 
was calculated as the peak fluorescence with the addition of chemoattractants over 
the average baseline fluorescence of the cells. as a positive control for the ability of 
cells to flux calcium, daTP was added at 120 seconds, with the following increases 
in ca2+ over baseline (cypa = 20%, MIP-2 = 22% and cypa + MIP-2 = 20%). These 
data are representative of 3 independent experiments.
Abbreviations: see list of abbreviations.
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Figure 5 actin polymerization increases when cypa and MIP-2 are combined. 
neutrophils were serum starved in RMPI for 30 minutes at room temperature 
before  Bsa  Fraction V  was  added.  cells  were  then  incubated  for  5  minutes 
at 37°c in: A) medium alone, 5 ng/ml cypa alone, 10 ng/ml MIP-2 alone, or a 
combination of cypa + MIP-2, or B) 20 ng/ml Kc alone, 5 ng/ml cypa alone, or a 
combination of cypa + Kc. The cells were immediately fixed in formalin followed 
by permeabilization in Triton X-100 and staining with FITc-conjugated phalloidin. 
MFI were calculated and are shown for each group in panel legends. C) Bar graph 
showing average increases in phalloidin expression relative to medium that were 
calculated using 2 independent sets of data.
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cell type.34 Our data fit this criterion in that the synergistic 
effect was seen only at very specific dose combinations. 
To provide support that the apparent synergistic interaction 
between CypA and MIP-2 was also associated with altered 
signaling events, several biochemical parameters were 
measured. Combinations of CypA and MIP-2 did indeed 
lead to an augmented internalization of CXCR2, increased 
and more prolonged calcium mobilization, and enhanced 
actin polymerization in neutrophils, although these changes 
were for the most part additive rather than synergistic. 
Similar discrepancies in functional outcome versus signal-
ing profiles have been reported during chemokine synergy 
by other laboratories.35,36 One possibility is that the specific 
parameters measured in the current studies are not directly 
associated with the signaling events required to mediate 
functional synergy between chemokines. However, a more 
likely explanation is that synergistic outcomes are due to the 
integration of multiple signaling events. Thus, while changes 
in one signaling parameter provide evidence for enhanced 
receptor-mediated events, these events may represent only 
one arm of an integrated signaling pathway.
Based on our current findings, we propose the following 
mechanism for the augmented activation of neutrophils by 
combinations of CypA and MIP-2. When the 2 chemoattrac-
tants are present together, CypA may promote greater and/
or more efficient binding of MIP-2 to its receptor CXCR2, 
resulting in increased CXCR2 internalization (Figure 3). 
The internalized receptor-chemokine (CXCR2-MIP-2) 
complexes may then contribute to increased signaling by 
promoting receptor recycling. Increases in downstream sig-
naling events are evidenced by an augmentation in calcium 
flux (Figure 4). The ensuing increase in actin polymerization 
(Figure 5) results in a more efficient migration by individual 
cells, or enables a greater total number of cells to migrate, due 
to previously sub-optimal thresholds of activation becom-
ing optimal. This is supported by in vivo observations that 
neutrophil numbers are still high as late as 24 hours after LPS 
delivery, yet inhibiting cyclophilins at this time point (when 
cyclophilins are at their peak level) reduces neutrophilia 
by only 40% to 50%.6 Co-inhibiting CypA and MIP-2 (or 
any additional chemokines found to cooperate with CypA) 
provides a potential approach whereby late neutrophil recruit-
ment might be further reduced, resulting in a decrease in the 
amplitude of the response and the collateral tissue damage 
associated with prolonged neutrophilia. Indeed, such an out-
come was reported when the synergizing chemokines, IL-8, 
and GM-CSF, were co-inhibited,28 providing preliminary 
support for this type of therapeutic intervention.
with KC, that resulted in augmented neutrophil migration. 
Although several different doses of KC were tested and failed 
to cooperate with CypA in the combination assays (data not 
shown), we cannot rule out the possibility that KC and CypA 
might be able to function in either an additive or synergistic 
partnership at doses not tested here. Nevertheless, the current 
findings suggest that partnerships between chemoattractants 
are likely selective. Recent studies suggest that the family 
to which a chemokine belongs is a critical parameter in 
determining whether cooperative interactions will occur. 
Specifically, these studies showed that chemokines belonging 
to the same family (for example CXC or CC) are less likely 
to interact due to their competing for related receptors and/
or using similar signaling pathways.20 Both MIP-2 and KC 
signal through the same receptor, CXCR2, suggesting that 
the interaction with CypA may occur at a step preceding 
receptor binding. A possible mechanism is that interactions 
between MIP-2 and CypA enhance MIP-2 binding and/or 
signaling through CXCR2, possibly via the peptidyl-prolyl 
isomerization activity of CypA.
The principal binding and signaling receptor for CypA 
is CD147, a type I integral membrane protein carrying 2 
immunoglobulin-like domains.30 Since CD147 bears no 
structural homology with any of the 4 major families of 
chemokine receptors (CR, CCR, CXCR, and CX3CR), extra-
cellular cyclophilins may be less restricted in their capacity 
to interact and synergize with other chemokines. However, 
it should be noted that the interaction between CypA/CypB 
and CD147 has also been shown to require the presence of 
cell surface heparans for optimal induction of cyclophilin 
binding and signaling.15,31 Recent studies have reported that 
syndecan-1 is the principal heparan co-receptor for CypB, 
which coordinates with CD147 to activate signaling pathways 
and induce T cell adhesion and migration.32 Interestingly, 
KC has also been shown to bind syndecan-1.33 The fact that 
syndecan-1 is implicated in both cyclophilin and KC signal-
ing pathways could provide an alternative explanation for 
why we did not observe any cooperation between these 2 
chemoattractants in the current studies: CypA and KC may 
compete for syndecan-1 binding, thus reducing their ability 
to signal through the corresponding receptor and preventing 
their capacity to interact.
Of particular interest was the observation that combina-
tions of CypA and MIP-2 mediated increases in neutrophil 
migration that were greater than additive, suggesting a syn-
ergistic interaction. The phenomenon of synergy between 
chemoattractants in vitro is typically observed only within 
narrow ranges of concentrations that greatly depend on the Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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Abbreviations
Ab, antibody; BAL, bronchoalveolar lavage; CsA, 
cyclosporine A; CypA, cyclophilin A; dATP, deoxyadenosine 
triphosphate; ELISA, enzyme-linked immunosorbent assay; 
FITC, fluorescein isothiocyanate; FLIPR, fluorescence 
imaging plate reader; fMLP, formyl-methionyl-leucyl-
phenylalanine; GM-CSF, granulocyte-macrophage colony-
stimulating factor; GCP, granulocyte chemoattractant protein; 
GPCR, G protein-coupled receptor; HRP, horseradish 
peroxidase; Ig, immunoglobulin; IP, interferon gamma-
induced protein; IL, interleukin; KC, keratinocyte chemoat-
tractant; LIX, lipopolysaccharide-induced CXC chemokine; 
LPS, lipopolysaccharide; mAB, monoclonal antibody; 
MCP, monocyte chemotactic protein; MDC, macrophage-
derived chemokine; MFI, mean fluorescence intensity; 
MIP, macrophage inflammatory protein; NAP, neutrophil 
activating protein; PBMC, peripheral blood mononuclear 
cell; PBS, phosphate buffered saline; PE, phycoerythrin; 
RANTES, regulated on activation, normally T cell expressed 
and secreted; RBC, red blood cell; SDS-PAGE, sodium 
dodecyl sulfate polyacrylamide gel electrophoresis; SE, 
standard error.
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Figure S1 Dose responses for cypa, MIP-2, and Kc-mediated mouse neutrophil 
chemotaxis. In vitro chemotaxis assays were set up using purified mouse neutrophils 
incubated in the presence of a single dose of fMLP (positive control) and increasing 
doses of cypa, MIP-2, and Kc. a chemotactic index was calculated for each group 
by dividing the number of migrated cells in test wells by the number of cells that 
migrated  to  medium  alone.  A)  Mean  ±  se  chemotactic  index  for  neutrophils 
incubated with fMlP and increasing doses of cypa. B) Mean ± se chemotactic index 
for neutrophils incubated with fMlP and increasing doses of MIP-2. C) Mean ± se 
chemotactic index for neutrophils incubated with fMlP and increasing doses of Kc. 
n = 6 wells for each group.
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